Henningsen, P, Martin, A · Deutsche medizinische Wochenschrift (1946) · 2013 · DOI
Quick Summary
ME/CFS is characterized by persistent, severe fatigue that cannot be traced to a known medical condition. This guideline emphasizes that ME/CFS should be understood as a functional somatic syndrome, meaning the body's systems aren't working optimally even though traditional tests may appear normal. Treatment recommendations include cognitive behavioral therapy and gradually increasing physical activity, which have shown evidence of benefit.
Why It Matters
This guideline provides structured clinical recommendations for ME/CFS diagnosis and management from established medical authorities, helping standardize care approaches across healthcare systems. It emphasizes the importance of addressing psychological and social factors alongside physical symptoms, which can improve diagnostic accuracy and treatment outcomes for patients.
Observed Findings
ME/CFS is characterized by enduring, disabling fatigue unexplained by known disease
Multiple diagnostic definitions exist with varying criteria and conceptual frameworks
High rates of comorbid medically unexplained somatic complaints occur in ME/CFS patients
Cognitive behavioral therapy shows evidence of effectiveness for CFS
Graded activity programs demonstrate evidence-based benefits for CFS
Inferred Conclusions
ME/CFS should be evaluated and managed using a comprehensive biopsychosocial approach rather than purely biomedical assessment
Cognitive behavioral therapy and graded activity are recommended as evidence-based treatment approaches for CFS
Functional somatic syndrome framework provides a useful conceptualization for understanding ME/CFS
Remaining Questions
What are the underlying biological mechanisms that cause ME/CFS?
How do individual differences in illness beliefs affect treatment response and prognosis?
What This Study Does Not Prove
This guideline does not establish the underlying biological mechanisms of ME/CFS or prove that psychological factors are the primary cause of the condition. It also does not present new empirical data comparing treatment efficacy; rather, it synthesizes existing evidence and provides recommendations for clinical practice.